Cytokinetics Insider Sold Shares Worth $491,783, According to a Recent SEC Filing-April 2024-www.financetom.com

Cytokinetics Insider Sold Shares Worth $491,783, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Cytokinetics Insider Sold Shares Worth $491,783, According to a Recent SEC Filing

Apr 15, 2026 3:08 PM

05:32 PM EDT, 04/15/2026 (MT Newswires) -- Andrew Callos, Executive Vice President, Chief Commercial Officer, on April 15, 2026, sold 7,449 shares in Cytokinetics ( CYTK ) for $491,783. Following the Form 4 filing with the SEC, Callos has control over a total of 58,555 common shares of the company, with 58,555 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000106198326000036/xslF345X05/form4.xml

Previous page： Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On? Next page： Popular Raises Dividend, Launches $500 Million Share Buyback Plan

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?

Jul 16, 2025

Sarepta Therapeutics Inc ( SRPT ) shares are soaring in Wednesday’s after-hours session after the company announced a strategic restructuring and cost-cutting measures. What To Know: After the market close on Wednesday, Sarepta Therapeutics ( SRPT ) introduced a strategic restructuring plan that involves focusing on high-value, high-impact programs and supporting long-term financials. Sarepta said it initiated immediate changes to...

Popular Raises Dividend, Launches $500 Million Share Buyback Plan

Jul 16, 2025

04:55 PM EDT, 07/16/2025 (MT Newswires) -- Popular (BPOP) said Wednesday it's increasing its quarterly dividend to $0.75 from $0.70 per share, starting with the dividend payable in Q4, subject to the approval of the board. The company also said it's launching a new share buyback program of up to $500 million, in addition to the $500 million program announced...

Sarepta to Cut 500 Jobs in Restructuring; Shares Rise After-Hours

Jul 16, 2025

05:00 PM EDT, 07/16/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said late Wednesday it's launching a restructuring plan that includes cutting expenses, delivering $400 million in annual cost savings, and implementing a 36% workforce reduction of about 500 employees. The company said the plan is designed to keep access to its $600 million revolving credit facility and generate...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...